Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Operating activities
Net income	$ 10,800,000	$ 19,400,000
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	247,000	241,000
Net amortization of investments	2,074,000	2,347,000
Change in investment related allowance for credit losses	(26,000)
Deferred income taxes	(481,000)	5,000
Net realized gains on investments	(992,000)	(59,000)
Net unrealized (gains) losses on equity securities	8,763,000	(2,158,000)
Share-based compensation	760,000	565,000
Changes in operating assets and liabilities:
Premiums receivable, net	(11,174,000)	(11,832,000)
Accrued interest receivable	(488,000)	(720,000)
Deferred policy acquisition costs	(671,000)	(699,000)
Other assets	234,000	(998,000)
Reserves for loss and loss adjustment expenses	6,396,000	2,171,000
Unearned premiums	5,298,000	5,730,000
Reinsurance balances	(9,658,000)	824,000
Amounts held for others and policyholder deposits	836,000	871,000
Accounts payable and other liabilities	3,294,000	4,588,000
Net cash provided by operating activities	15,212,000	20,276,000
Investing activities
Purchases of investments held-to-maturity	(26,201,000)	(26,174,000)
Purchases of investments available-for-sale	(21,592,000)	(10,394,000)
Purchases of equity securities	(8,770,000)	(807,000)
Purchases of short-term investments	(40,250,000)	(64,320,000)
Proceeds from maturities of investments held-to-maturity	22,018,000	40,578,000
Proceeds from sales and maturities of investments available-for-sale	47,812,000	26,365,000
Proceeds from sales and maturities of short-term investments	52,959,000	13,959,000
Purchases of property and equipment	(221,000)	(22,000)
Net cash provided by (used in) investing activities	25,755,000	(20,815,000)
Financing activities
Proceeds from stock option exercises		19,800
Finance lease purchases	(12,000)	(12,000)
Dividends to shareholders	(5,245,000)	(4,918,000)
Net cash used in financing activities	(5,257,000)	(4,910,000)
Change in cash and cash equivalents	35,710,000	(5,449,000)
Cash and cash equivalents at beginning of period	43,813,000	40,344,000
Cash and cash equivalents at end of period	$ 79,523,000	$ 34,895,000